STUDY OF THE IMPACT OF E-PRESCRIPTION IMPLEMENTATION ON THE SALE OF ANTIBACTERIAL DRUGS FOR SYSTEMIC USE FROM PHARMACIES ON THE EXAMPLE OF CHLORAMPHENICOL
DOI:
https://doi.org/10.11603/2312-0967.2024.2.14749Keywords:
antibacterial medicines, electronic prescription, chloramphenicol, pharmacies, sales volumesAbstract
The aim of the work. The aim of the study was to analyse the impact of the introduction of electronic prescriptions for antibacterial medicines of group J01 on their sale from pharmacies on the example of chloramphenicol medicines.
Materials and Methods. The study was based on the regulatory legal acts on the regulation of antibacterial medicines, as well as on the management accounting data of pharmacies that are part of all-Ukrainian pharmacy chains and are located in cities, towns and villages in all regions of Ukraine. The methods used were content analysis, retrospective and statistical analysis, graphical methods and generalisation.
Results and Discussion. It was found that the sales of chloramphenicol in physical terms in 2022 were without significant seasonal fluctuations, while it was determined that in July 2022, after the announcement by the Ministry of Health of Ukraine of the introduction of an e-prescription as part of strengthening control over the circulation of antibacterial medicines and media coverage of this news, there was a significant increase in sales of chloramphenicol from all manufacturers in all doses. In addition, in August 2022, after the introduction of the e-prescription, sales of chloramphenicol in physical terms not only did not decrease but remained higher than in previous months.
The analysis of the average volume of chloramphenicol sales in physical terms by one pharmacy in 2022-2023 showed that in March and April 2023, the volume of chloramphenicol sales by one pharmacy increased by 81% and 22.73%, respectively, compared to 2022.
Conclusions. The analysis shows that the introduction of e-prescription as an additional regulatory mechanism for the circulation of antibacterial medicines was ineffective for chloramphenicol. The announcement of changes in the organisation of prescription supply of antibacterial medicines led to a spontaneous, clinically unjustified agitated demand among the population for medicines in this group when there is an increase in sales, in this case of chloramphenicol, which does not correlate with a particular disease, as confirmed by data for previous years in the same period.
References
Wohlleben W, Mast Y, Stegmann E, Ziemert N. Antibiotic drug discovery. Microb Biotechnol. 2016;9(5):541-548. DOI:10.1111/1751-7915.12388.
Mohr KI. History of Antibiotics Research. Curr Top Microbiol Immunol. 2016;398:237-272. DOI:10.1007/82_2016_499.
Lewis K. The Science of Antibiotic Discovery. Cell. 2020;181(1):29-45. DOI: 10.1016/j.cell.2020.02.056
Pulingam T, Parumasivam T, Gazzali AM, et al. Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2022;170:103-106. DOI:10.1016/j.ejps.2021.106103
Clark NM, Zhanel GG, Lynch J.P 3rd. Emergence of antimicrobial resistance among Acinetobacter species: a global threat. Current opinion in critical care; 2016;22(5):491–499. DOI: 10.1097/MCC.0000000000000337.
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022; 399(10325):629-655. DOI: 10.1016/S0140-6736(21)02724-0
World Health Organization. Antimicrobial stewardship interventions: a practical guide. 2021 [Internet]. [cited 2024 Feb 28]. Available from: https://www.euro.who.int/en/publications/abstracts/antimicrobial-stewardship-interventions-a-practicalguide-2021
WHO. Global health sector strategy on viral hepatitis 2016–2021. [Internet]. [cited 2024 Feb 28]. Available from: https://www.emcdda.europa.eu/drugs-library/who-global-health-sector-strategy-viral-hepatitis-2016-2021_en.
WHO. Global action plan on antimicrobial resistance [Internet]. [cited 2024 Feb 28]. Available from: https://iris.who.int/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1
World Health Organization. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. World Health Organization. 2020 [Internet]. [cited 2024 Feb 28]. Available from: https://iris.who.int/handle/10665/332081.
Global Antimicrobial Resistance and Use Surveillance System (GLASS) report: 2021. Geneva: World Health Organization. 2021 [Internet]. [cited 2024 Feb 28]. Available from: https://www.who.int/publications/i/item/9789240027336
Volkova A, Tereshchenko L, Korzh Yu. Otsinka stanu retsepturnoho vidpusku v umovakh vprovadzhennia elektronnoho retseptu v Ukraini. Farmatsevtychna osvita, nauka ta praktyka: stan, problemy, perspektyvy rozvytku : materialy nauk.-prakt. konf. z mizhnar. uchastiu, prysviachenoi 25-richchiu farmatsevt. f-tu Nats. med. un-tu imeni O. O. Bohomoltsia, m. Kyiv, 19-20 hrud. 2023 r. Kyiv, 2023. P.275-277.
Volkova AV, Tereshchenko LV, Zhirova IV. Analysis of the problems of the rational use of antibacterial drugs in Ukraine. Sotsialna farmatsiia v okhoroni zdorovia, 2019;5(3):4-12. DOI: 10.24959/sphhcj.19.157
Yakovlieva LV, Bahlai TO, Khomenko OV. Porivnialnyi analiz antymikrobnykh likarskykh zasobiv, rekomendovanykh medyko-tekhnolohichnymy dokumentamy dlia likuvannia khvorykh na nehospitalnu pnevmoniiu. Farmatsevtychnyi zhurnal, 2019;2:38-44. DOI: 10.32352/0367-3057.2.19.04
Baranova D, Korzh Yu, Tereshchenko L. Otsinka stanu vprovadzhennia elektronnoho retsepta v Ukraini Youth Pharmacy Science : materialy IV Vseukrainskoi naukovopraktychnoi konferentsii z mizhnarodnoiu uchastiu (6-7 hrudnia 2023 r., m. Kharkiv). Kharkiv: NFaU, 2023. P. 481-482
Pro zatverdzhennia Pravyl vypysuvannia retseptiv ta vymoh-zamovlen na likarski zasoby i vyroby medychnoho pryznachennia… : Nakaz MOZ Ukrainy vid 19.07.2005 r. No 360 [Internet]. [cited 2024 Feb 28] Available from: http://zakon5.rada.gov.ua/laws/show/z0782-05
Pro zatverdzhennia Zmin do deiakykh normatyvno-pravovykh aktiv Ministerstva okhorony zdorovia Ukrainy : Nakaz MOZ Ukrainy vid 21.07.2022 r. No 1284 [Internet]. [cited 2024 Feb 28] Available from: https://zakon.rada.gov.ua/laws/show/z0826-22#Text
Yakovlieva L. V., Bahlai T. O. J01B amfenikoly: analiz farmatsevtychnoho rynku ta struktura spozhyvannia u 2013-2019 rokakh. Naukovyi pidkhid do sfery praktychnoi kosmetolohii: aktualni pytannia y trendy : materialy Mizhnarodnoi naukovo-praktychnoi konferentsii (11 bereznia 2020 r. m. Kharkiv). Kharkiv: NFaU, 2020. P. 210-213.
Shtuchna N. I., Vyshnevska L. I., Khomenko V. M. Poshuk aktyvnykh inhrediientiv dlia rozrobky protymikrobnykh preparativ kompleksnoi dii dlia zovnishnoho zastosuvannia. Suchasni dosiahnennia farmatsevtychnoi tekhnolohii i biotekhnolohii : materialy IKh Mizhnarodnoi naukovo-praktychnoi konferentsii (m. Kharkiv, 11-12 lystopada 2021 r.). Kharkiv: NFaU, 2021. P. 243-245.
National Library of Medicine [Internet]. [cited 2024 Feb 28] Available from: https://pubmed.ncbi.nlm.nih.gov/
World Health Organization. 2019. WHO AWaRe Classification Database of Antibiotics for evaluation and monitoring of use. 2021 [Internet]. [cited 2024 Feb 28] Available from: https://www.who.int/news/item/01-10-2019-who-releases-the-2019-awareclassification-antibiotics
World Health Organization. AWaRe Policy Brief [Internet]. [cited 2024 Feb 28] Available from: https://adoptaware.org/assets/pdf/aware_ policy_brief.pdf
Džupová O, Beneš J. Role of chloramphenicol in current clinical practice. Klin Mikrobiol Infekc Lek. 2022;28(4):101-105.
Wareham DW, Wilson P. Chloramphenicol in the 21st century. Hosp Med. 2002;63(3):157-61. DOI: 10.12968/hosp.2002.63.3.2061.
Rynok antybiotykiv v Ukraini ta zakhody borotby z antybiotykorezystentnistiu. Shchotyzhnevyk Apteka, 2023;16(1387) [Internet]. [cited 2024 Feb 28] Available from: https://www.apteka.ua/article/664077
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
